Coping with Cancer

You are here

Coping with Cancer

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:
Disease Learning:
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
Cancer Journey:
Cancer Type:

Articles

Download slides from LIVE WEBCAST of November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Cancer Journey:
Cancer Type:
Head & Neck Cancers Frequently Asked Questions Written by Joshua Bauml, MD September 2017 What is it? “Head and neck cancer” is an umbrella term...
Cancer Journey:
Cancer Type:
Disease Learning:
Malignant Hematology Progress in understanding DNA changes in lymphoma has already provided improved and highly sensitive tests for detecting this...
Cancer Journey:
Cancer Type:
To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Cancer Journey:
Cancer Type:
Disease Learning:

Community Forum

Hello, I have alk + Stage IV NSCLC since 2008. Five years ago I went on Brigatinib for asymptomatic brain mets with great results. In Jan, several...
Cancer Journey:
Cancer Type:
Disease Learning:
I have NSCLC EFGR exon 19 deletion and had 2 VATS, Tarceva and have been on Tagrisso for over 20 months. I have been on a two week break because of...
Cancer Journey:
Cancer Type:
Disease Learning:
Hello there! I have reached out for your thoughts before and so appreciate your expertise. Thank you! I am back with another question and could...
Cancer Journey:
Cancer Type:
Disease Learning:
My sister-in-law was diagnosed 10 years ago with stage 4 adenocarcinoma, with what now would be considered oligiomestastic disease. She had 6 rounds...
Cancer Journey:
Cancer Type:
Disease Learning:
I have psoriasis (along with my stage IV NSCLC ALK Positive) I am taking Alectinib for the NSCLC. Is it OK to take a biologic like Cosentyx, Stelara...
Cancer Journey:
Cancer Type:
Disease Learning: